BackCytomX Therapeutics Overview
CytomX Therapeutics Inc

CytomX Therapeutics Target Price

See CytomX Therapeutics's analyst price targets ($8.5) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.32

Average Target Price

$8.50156% upside

2 analysts in the last 4 months

High: $11 | Low: $6

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-19Wolfe Research$680.7% upsideOpen
2026-05-11H.C. Wainwright$11231.3% upsideOpen
2026-03-18JefferiesRoger Song$16381.9% upsideOpen
2026-03-16OppenheimerMatthew Biegler$12261.4% upsideOpen
2026-02-04Barclays$10201.2% upsideOpen
2026-01-20Piper Sandler$10201.2% upsideOpen
2026-01-20GuggenheimMichael Schmidt$10201.2% upsideOpen
2026-01-20BarclaysEtzer Darout$8141% upsideOpen
2025-10-21BarclaysEtzer Darout$680.7% upsideOpen
2025-09-16BarclaysEtzer Darout$3.55.4% upsideOpen
2025-07-31OppenheimerMatthew Biegler$7110.8% upsideOpen
2024-11-08BMO CapitalEtzer Darout$3.6810.8% upsideOpen
2024-11-08Piper SandlerJoseph Catanzaro$3.252.1% downsideOpen
2024-08-09BMO CapitalEtzer Darout$3.567.2% upsideOpen
2024-05-27Piper SandlerJoseph Catanzaro$3.55.4% upsideOpen
2024-05-09BMO CapitalEtzer Darout$3.598.1% upsideOpen
2024-05-09WedbushRobert Driscoll$8141% upsideOpen
2024-05-05JefferiesRoger Song$8141% upsideOpen
2024-03-12JefferiesRoger Song$2.524.7% downsideOpen
2024-03-12BMO CapitalEtzer Darout$3.252.1% downsideOpen
2023-01-06BMO Capital$3.23.6% downsideOpen
2022-11-14BMO Capital$2.621.7% downsideOpen

CytomX Therapeutics (CTMX) FAQ

The latest target price for CTMX is $8.5. Investors often review this figure alongside CytomX Therapeutics's historical trend and sector peers before judging valuation or financial health.

CytomX Therapeutics trades near $3.32 while the consensus target sits at $8.5 (156.0% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting CTMX's target price ($8.5), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack CytomX Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.